Analysed HIMS & HERS HEALTH INC (HIMS:NYSE) News Sources
Hims & Hers Health (HIMS) Gains On FDA Panel News, Is The Valuation Gap Still Wide?
23-07-2026
yahoo.com
HIMS Stock Climbs Overnight As FDA Advisory Panel Backs 4 Peptides — ‘Pharma Bro’ Martin Shkreli Goes Short
24-07-2026
stocktwits.com
Does FDA Peptide Shift and CAO Exit Reframe the Bull Case for Hims & Hers Health (HIMS)?
24-07-2026
yahoo.com
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
24-07-2026
yahoo.com
A Hims cofounder fired his marketing agency for an AI-powered team. Now his 24/7 online vet service is growing 20% a month
25-07-2026
yahoo.com
What is the current price of HIMS & HERS HEALTH INC (HIMS:NYSE)?
The current price of HIMS & HERS HEALTH INC (HIMS:NYSE) is $28.5.
HIMS & HERS HEALTH INC (HIMS:NYSE) absolute price change since previous trading day?
The absolute price change of HIMS & HERS HEALTH INC (HIMS:NYSE) since the previous trading day is $-1.74.
HIMS & HERS HEALTH INC (HIMS:NYSE) percentage price change since previous trading day?
The percentage price change of HIMS & HERS HEALTH INC (HIMS:NYSE) since the previous trading day is -5.754%.
What is the most recent average sentiment score for HIMS & HERS HEALTH INC (HIMS:NYSE)?
The most recent average sentiment score for HIMS & HERS HEALTH INC (HIMS:NYSE) is 59 out of 100.
What is the most recent average sentiment for HIMS & HERS HEALTH INC (HIMS:NYSE)?
The most recent sentiment for HIMS & HERS HEALTH INC (HIMS:NYSE) is .
SEC-8K** Filing Available For HIMS & HERS HEALTH INC (HIMS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.